SCHEMBL25199371

SCHEMBL25199371

CCOC(=O)C1(NC(=O)c2ccccc2)CC(O)C(F)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.42
FAAH O00519 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
GAA P10253 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
CTSL P07711 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ADAM17 P78536 1/20 0.38
CTSK P43235 1/20 0.38
CHRM5 P08912 3/20 0.38
MAPK1 P28482 1/20 0.38
CYP2C19 P33261 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM3 P20309 1/20 0.38
ALDH1A1 P00352 1/20 0.37
CHRM1 P11229 3/20 0.36
CHRM4 P08173 1/20 0.36
DGAT2 Q96PD7 1/20 0.36
OPRM1 P35372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25196454 0.82 ALDH1A1 (0.39) HSD17B10FAAHSMN1; SMN2GAANPC1
SCHEMBL23833796 0.82 MAPK1 (0.48) HSD17B10FAAHSMN1; SMN2GAANPC1
SCHEMBL1740344 0.81 SMN1; SMN2 (0.50) HSD17B10SMN1; SMN2GAANPC1RAB9A
SCHEMBL25492303 0.76 GAA (0.44) HSD17B10SMN1; SMN2GAAKDM4EADAM17
SCHEMBL25492257 0.74 MEN1 (0.34) CTSLMAPK1CYP2C19ALDH1A1MEN1
SCHEMBL25492182 0.74 MEN1 (0.34) CTSLMAPK1CYP2C19ALDH1A1MEN1
SCHEMBL23833804 0.74 MEN1 (0.34) CTSLMAPK1CYP2C19ALDH1A1MEN1
SCHEMBL25492269 0.74 MEN1 (0.34) CTSLMAPK1CYP2C19ALDH1A1MEN1
SCHEMBL11642022 0.74 HSD17B10 (0.44) HSD17B10SMN1; SMN2GAANPC1RAB9A
SCHEMBL9231221 0.72 MEN1 (0.47) GAAKDM4ECHRM2CHRM3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158178-A1 Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof UNIV EMORY (US) 2023-05-25 US disclosed
EP-4121121-A1 RADIONUCLIDE TRACERS OF 1-AMINO-3,4-DIFLUOROCYCLOPENTANE-1-CARBOXYLIC ACID, DERIVATIVES, AND USES THEREOF Emory University (US) 2023-01-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158178-A1 Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof AFF1, METTL3, VHL HSD17B10 3448/4885FAAH 438/4885SMN1; SMN2 2707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.